Le produit a bien été ajouté au panier.

discount label
H-FLRGRAYGL-OH
Vue en 3D

Biosynth logo

H-FLRGRAYGL-OH

Ref. 3D-PH00153

1mg
244,00 €
10mg
285,00 €
100mg
460,00 €
Livraison estimée en/au États-Unis, le lundi 31 mars 2025

Informations sur le produit

Nom :
H-FLRGRAYGL-OH
Synonymes :
  • H-Phe-Leu-Arg-Gly-Arg-Ala-Tyr-Gly-Leu-acid CEF16
  • Epstein - Barr Virus latent NA - 3A (337 - 347)
Description :

Peptide H-FLRGRAYGL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FLRGRAYGL-OH include the following: In Vitro Studies of MHC Class I Peptide Loading and Exchange M Bouvier - Antigen Processing: Methods and Protocols, 2019 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-9450-2_6 T-cell receptor binding affects the dynamics of the peptide/MHC-I complex B Knapp , CM Deane - Journal of Chemical Information and ..., 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jcim.5b00511 A structural basis for varied αβ TCR usage against an immunodominant EBV antigen restricted to a HLA-B8 molecule S Gras , PG Wilmann, Z Chen, H Halim- The Journal of ..., 2012 - journals.aai.orghttps://journals.aai.org/jimmunol/article/188/1/311/39100 Insights into the structure of the LC13 TCR/HLA-B8-EBV peptide complex with molecular dynamics simulations A Stavrakoudis - Cell biochemistry and biophysics, 2011 - Springerhttps://link.springer.com/article/10.1007/s12013-011-9151-2 A Structural Basis for Varied SRB Purcell, J McCluskey , J Halim, YC Liu- 2011 - academia.eduhttps://www.academia.edu/download/49937131/311.full.pdf Preferential binding of unusually long peptides to MHC class I and its influence on the selection of target peptides for T cell recognition JM Burrows, MJ Bell, R Brennan, JJ Miles - Molecular ..., 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589007007870 Amino acid 95 causes strong alteration of peptide position PΩ in HLA-B* 41 variants C Bade-Doeding, DS DeLuca , A Seltsam, R Blasczyk - Immunogenetics, 2007 - Springerhttps://link.springer.com/article/10.1007/s00251-007-0197-7 Analysis of interactions in a tapasin/class I complex provides a mechanism for peptide selection M Chen , M Bouvier - The EMBO journal, 2007 - embopress.orghttps://www.embopress.org/doi/abs/10.1038/sj.emboj.7601624 The structure of the human allo-ligand HLA-B* 3501 in complex with a cytochrome p450 peptide: Steric hindrance influences TCR allo-recognition CS Hourigan , M Harkiolaki , NA Peterson- European journal of ..., 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200636234 Alloreactivity between disparate cognate and allogeneic pMHC-I complexes is the result of highly focused, peptide-dependent structural mimicry JK Archbold , WA Macdonald , JJ Miles - Journal of Biological ..., 2006 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)70616-2/fulltext Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection LK Ely, KJ Green, T Beddoe , CS Clements- The Journal of ..., 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/174/9/5593/72504 T cell receptor recognition of a'super-bulged'major histocompatibility complex class I-bound peptide FE Tynan, SR Burrows , AM Buckle , CS Clements- Nature ..., 2005 - nature.comhttps://www.nature.com/articles/ni1257 Novel strategy for identification of candidate cytotoxic T-cell epitopes from human preproinsulin L Chang, L Kjer-Nielsen, S Flynn, AG Brooks - Tissue ..., 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1399-0039.2003.00122.x Cutting edge: the minor histocompatibility antigen H60 peptide interacts with both H-2Kb and NKG2D A Cerwenka, CA O'Callaghan- The Journal of ..., 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/7/3131/34975 The structure of HLA-B8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization L Kjer-Nielsen, CS Clements, AG Brooks - The Journal of ..., 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/169/9/5153/75164 The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state CS Clements, L Kjer-Nielsen- Section D: Biological ..., 2002 - journals.iucr.orghttps://journals.iucr.org/d/issues/2002/12/00/cy0066/cy0066.pdf Peptide-MHC class I tetrameric complexes display exquisite ligand specificity SR Burrows , N Kienzle, A Winterhalter- The Journal of ..., 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/11/6229/33743 The relationship between the cell surface density and the immunogenicity of multiple Epstein-Barr virus epitopes VL Crotzer - 2000 - search.proquest.comhttps://search.proquest.com/openview/06a0758b23e4b23671968815a6781078/1?pq-origsite=gscholar&cbl=18750&diss=y Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA M Subklewe, A Chahroudi - Blood, The Journal ..., 1999 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/94/4/1372/249676 Differences in the recognition by CTL of peptides presented by the HLA-B* 4402 and the HLA-B* 4403 molecules which differ by a single amino acid J Herman, V Jongeneel , D Kuznetsov- Tissue ..., 1999 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1034/j.1399-0039.1999.530201.x The immunostimulatory effect of bio-active peptide from pollen on murine and human lymphocytes J Liu, S Wang, J Qi, X Wang, Y Song - Mechanisms of ageing and ..., 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0047637498000633 Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire SR Burrows , SL Silins, SM Cross- European journal of ..., 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830270126 -Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells SR Burrows , SL Silins, R Khanna - European journal of ..., 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830270720 T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. SR Burrows , SL Silins, DJ Moss, R Khanna - The Journal of ..., 1995 - rupress.orghttps://rupress.org/jem/article-abstract/182/6/1703/25482 Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line R Khanna , SR Burrows , V Argaet- International ..., 1994 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/6/4/639/714413 Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccination. A Suhrbier , SR Burrows , A Fernan- (Baltimore, Md.: 1950 ..., 1993 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/150/6/2169/25848 The specificity of recognition of a cytotoxic T lymphocyte epitope SR Burrows , SJ Rodda, A Suhrbier - European journal of ..., 1992 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830220128 Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing. SR Burrows , A Suhrbier , R Khanna , DJ Moss - Immunology, 1992 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1421752/ Inhibition of HLA B8-restricted recognition by unrelated peptides: evidence for allosteric inhibition A Fernan, SR Burrows , DJ Moss, A Saul , A Suhrbier - Immunology letters, 1991 - Elsevierhttps://www.sciencedirect.com/science/article/pii/016524789190048F

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PH00153 H-FLRGRAYGL-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

  • Choisissez l’indicatif du pays du téléphone.
  • Spain (España)+34
  • Portugal+351
  • Germany (Deutschland)+49
  • France+33
  • Italy (Italia)+39
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1
  • Andorra+376
  • Angola+244
  • Anguilla+1
  • Antigua and Barbuda+1
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1
  • Guadeloupe+590
  • Guam+1
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1
  • Saint Lucia+1
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1
  • Tuvalu+688
  • U.S. Virgin Islands+1
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
  • Choisissez l’indicatif du pays du téléphone.
* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".